Description
Investor Evening in Edinburgh on Wednesday 12 September 2018 and listen to and meet Directors of listed companies. The event gives you the chance to come along and meet the key people at companies you might like to invest in. That counts for a lot. You get to speak to business leaders and company insiders face to face…
You get to find out how their business is doing… what challenges they may be facing… and what they’re going to do to give them the best chance of giving you a decent return on your investment. It’s a brilliant chance to get a far better picture of your potential investments.
Companies presenting:
Mercia Technologies (MERC) is a national investment group focused on the funding and scaling of innovative businesses with high growth potential from the UK regions. Initially this is through Mercia’s managed funds and then selectively scaling businesses through its own balance sheet capital.
SkinBioTherapeutics (SBTX) is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company is targeting three specific skin healthcare sectors; cosmetics, infection control and eczema.
Tekcapital (TEK) is a UK IP investment group focused on creating market value from university technology. They accomplish this by acquiring, enhancing and developing bright new discoveries from their network of over 4,500 universities and research centres in 160 countries.
Thor Mining (THR) is an exploration and development company with an advanced tungsten/molybdenum project poised for development, a growing tungsten resource, an exciting copper development project, and a lithium exploration project.
Trafalgar Property Group (TRAF) operates two trading divisions namely Trafalgar New Homes Ltd and Trafalgar Retirement+ Ltd. Trafalgar New Homes is a successful Regional property developer based in the South-East of England while Trafalgar Retirement+ has experience in land assembly and residential development, and its focus is in the housing and care for the elderly market.
VolitionRx is a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers. The tests are based on the technology platform of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present.
Who Should Attend
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
This is a free event.